MUC21: a new target for tumor treatment
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Mucin 21 (MUC21), or Epiglycanin, is a glycoprotein implicated in various cancers. Its distinct expression in tumors suggests potential as a novel therapeutic target for cancer treatment.
Area Of Science
- Biochemistry
- Molecular Biology
- Oncology
Background
- Mucin 21 (MUC21), also known as Epiglycanin, is a high-molecular-weight glycoprotein with transmembrane mucin properties.
- MUC21 exhibits characteristic expression patterns in normal tissues such as the thymus, testes, lungs, and large intestine.
- Aberrant MUC21 expression is observed in various cancers, including esophageal squamous cell carcinoma, lung adenocarcinoma, glioblastoma, thyroid cancer, and melanoma.
Purpose Of The Study
- To provide a comprehensive review of MUC21's glycosylation and function.
- To summarize the current research progress on MUC21 in cancer and infectious diseases.
- To explore the potential of MUC21 as a therapeutic target in oncology.
Main Methods
- Literature review of existing research on MUC21.
- Analysis of MUC21 expression patterns in normal and malignant tissues.
- Investigation of MUC21's role in tumor invasion, metastasis, and prognosis.
Main Results
- MUC21's structure comprises tandem repeat, stem, transmembrane, and cytoplasmic tail domains.
- MUC21 expression is significantly altered in multiple types of cancer.
- Tumor invasion, metastasis, and poor prognosis are associated with MUC21 expression.
Conclusions
- MUC21 plays a role in the progression of various cancers.
- MUC21's unique expression profile makes it a promising candidate for targeted cancer therapy.
- Further research into MUC21 glycosylation and function is warranted for therapeutic development.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.